Seeking Alpha
 

CVS Health Corporation (CVS)

- NYSE
Show Summaries  |  Hide Summaries
  • Aug. 14, 2012, 6:15 PM
    Bespoke posts tables of sell-side analysts' most loved and most hated S&P 500 stocks. Eight boast at least 90% Buy ratings: SLM, A, SLB, CVS, ATI, COV, FLR, EMC. Take analyst recommendations with a fistful of salt but they're at least a sentiment indicator; note "the most loathed stock of all" - Sears (SHLD) - is up more than 70% YTD.
    | 5 Comments
  • Aug. 14, 2012, 8:25 AM
    The FTC yesterday said pharmaceutical companies are delaying generic competition by making patent settlement agreements in which they pledge not to launch their own copycat medicines. The FTC made the comments in a case involving CVS and Rite Aid (RAD), which are suing Pfizer (PFE) and TEVA for conspiring to keep generic versions of the antidepressant Effexor XR out of stores.
    | 4 Comments
  • Aug. 8, 2012, 9:25 AM
    Shares of CVS Caremark (CVS) ride a timely upgrade from BMO Capital higher. Analysts cite increased earnings potential and less uncertainty on the impact of the Walgreen-Express Script dispute on results as they raise their rating on the drugstore chain to Outperform from Market Perform. CVS +1.1% premarket.
    | Comment!
  • Aug. 7, 2012, 7:25 AM
    More on CVS Caremark (CVS): Pharmacy Services sales up 28.2% Y/Y to $18.4B, led by new client starts and drug cost inflation. Retail Pharmacy 6.9% higher to $15.8B, with Walgreen-Express Scripts dispute impacting results. Raises and narrows full-year EPS to $3.32-$3.38, up from prior guidance of $3.23-$3.33. (PR)
    | Comment!
  • Aug. 7, 2012, 7:07 AM
    CVS Caremark (CVS): Q2 EPS of $0.81 beats by $0.02. Revenue of $30.7B misses by $270M
    | 5 Comments
  • Aug. 7, 2012, 12:05 AM
    Notable earnings before Tuesday’s open: AKRX, AMRC, APU, ARCC, ARCO, BPI, CHD, CRZO, CVC, CVS, DWRE, EBIX, EMR, ENDP, EXPD, FE, FOSL, GTE, HL, HPT, KITD, KWK, MEA, MGM, MMC, MNKD, MPEL, NIHD, ODP, PCG, POM, SIRI, SOL, STWD, TAP, THC, TIE
    | Comment!
  • Aug. 6, 2012, 5:30 PM
    Notable earnings before Tuesday’s open: AKRX, AMRC, APU, ARCC, ARCO, BPI, CHD, CRZO, CVC, CVS, DWRE, EBIX, EMR, ENDP, EXPD, FE, FOSL, GTE, HL, HPT, KITD, KWK, MEA, MGM, MMC, MNKD, MPEL, NIHD, ODP, PCG, POM, SIRI, SOL, STWD, TAP, THC, TIE
    | 1 Comment
  • Aug. 3, 2012, 1:00 PM
    CVS Caremark (CVS -0.9%) trades lower after Cleveland Research warns that the number of accounts that it loses back to Walgreen from returning customers may be even more than the 50% it forecast earlier this month. Promotional activity and advertising from Walgreen may be contributing to the extra pharmacy account losses.
    | 1 Comment
  • Jul. 19, 2012, 10:35 AM
    CVS Caremark (CVS -4.4%) weighs in on the impact of the new Walgreen-Express Scripts agreement. The drugstore operator adds $0.05 to its overall FY12 estimate of extra business from the WAG-ESRX dispute after factoring in that it will retain 50% of the customers it gained from Walgreen through Q4.
    | Comment!
  • Jul. 19, 2012, 9:10 AM
    Premarket gainers: MLNX +42%. SCSS +21%. GGC +16%. NOK +13%. WAG +11%. SWKS +10%. TXT +9%. EDU +8%. EBAY +8%. ALU +7%. QCOM +6%. PPG +5%. LUV +5%.
    Losers: ANTH -15%. DCIX -15%. JCI -8%. CVS -6%.
    | Comment!
  • Jul. 19, 2012, 8:17 AM
    Shares of CVS Caremark (CVS) fall off 7.9% premarket after Walgreen and Express Scripts hash out a new pharmacy network agreement. The company had been one of the biggest beneficiaries of the WAG-ESRX dispute.
    | 1 Comment
  • Jul. 17, 2012, 6:54 AM
    JMP Securities resumes coverage on CVS Caremark (CVS) with an Outperform rating. Analysts set a $55 price target on shares, repping 16% upside potential for shares. The company has also seen a pickup in insider buying this month.
    | Comment!
  • Jul. 11, 2012, 1:29 PM
    CVS Caremark (CVS -0.2%) looks like a good defensive long-term play, according to Stephanie Link. She likes management's focus on quality of contracts over pricing and sees a continual grab of market share from Walgreen. If the WAG-ESRX continues to the end of the year, factor in another $0.02-$0.03 to the bottom line of CVS.
    | 2 Comments
  • Jul. 5, 2012, 1:54 PM
    CVS Caremark (CVS) dividend alert: Declares $0.1625/share quarterly dividend, in line with previous. Dividend yield 1.3%. For shareholders of record July 23; payable Aug 03; ex-div date July 19. (PR)
    | Comment!
  • Jun. 28, 2012, 1:39 PM
    While the Supreme Court opinion on healthcare is being called a drag on the retail sector by industry insiders, especially so for high-growth stories such as Chipotle (CMG -4.6%), Starbucks (SBUX -2.1%), and Dunkin' Brands (DNKN -3.2%), NBG's Brian Sozzi suggests a way to trade the news. He throws out WAG, CVS, and TGT as retail names that already have their employee structure in place and could be good long-term plays under the current retail environment.
    | 5 Comments
  • May 25, 2012, 8:00 AM
    Wal-Mart (WMT) says it's seeing good results with a pilot program of small-sized stores called Walmart Express. Execs say the stores are showing profits and the company could roll out hundreds more in the near future. Designed to catch spur-of-the-moment shoppers and small enough to tuck into tight spaces, Walmart Express stores could pose a threat to Walgreen (WAG), CVS Caremark (CVS), and Rite Aid (RAD) in the future.
    | 10 Comments
Visit Seeking Alpha's
CVS vs. ETF Alternatives
Company Description
CVS Health Corp iis an integrated pharmacy health care provider. The Company has three segments: Pharmacy Services, Retail Pharmacy and Corporate.
Sector: Healthcare
Industry: Drug Stores
Country: United States